You have free access to this content

BJU International

Cover image for Vol. 113 Issue 5b

Special Issue: Focus on Urological Oncology

May 2014

Volume 113, Issue 5b

Pages E17–E177

  1. Bladder

    1. Top of page
    2. Bladder
    3. Kidney
    4. Prostate
    5. Urothelial Carcinoma
    6. Translational Science
    1. You have free access to this content
      Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients (pages E17–E21)

      R. Houston Thompson, Stephen A. Boorjian, Simon P. Kim, John C. Cheville, Prabin Thapa, Robert Tarrel, Roxana Dronca, Brian Costello and Igor Frank

      Version of Record online: 5 SEP 2013 | DOI: 10.1111/bju.12274

    2. You have free access to this content
      Prognostic value of inflammation or granuloma after intravesival BCG in non-muscle-invasive bladder cancer (pages E22–E27)

      Samer Jallad, Stephanie Goubet, Andrew Symes, Timothy Larner and Philip Thomas

      Version of Record online: 20 DEC 2013 | DOI: 10.1111/bju.12334

    3. You have free access to this content
      Clinical significance of ureteric ‘skip lesions’ at the time of radical cystectomy: the M.D. Anderson experience and literature review (pages E28–E33)

      Anthony N. Hoang, Piyush K. Agarwal, Annerleim Walton-Diaz, Christopher G. Wood, Adam R. Metwalli, Wassim Kassouf, Gordon A. Brown, Peter C. Black, Diana L. Urbauer, H. Barton Grossman, Colin P.N. Dinney and Ashish M. Kamat

      Version of Record online: 23 APR 2014 | DOI: 10.1111/bju.12344

    4. You have free access to this content
    5. You have free access to this content
      Extended vs non-extended pelvic lymph node dissection and their influence on recurrence-free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta-analysis of comparative studies (pages E39–E48)

      Liangkuan Bi, Hai Huang, Xinxiang Fan, Kaiwen Li, Kewei Xu, Chun Jiang, Hao Liu, Wen Dong, Simin Zhang, Xiangyun Yang, Tianxin Lin and Jian Huang

      Version of Record online: 23 APR 2014 | DOI: 10.1111/bju.12371

  2. Kidney

    1. Top of page
    2. Bladder
    3. Kidney
    4. Prostate
    5. Urothelial Carcinoma
    6. Translational Science
    1. You have free access to this content
      The 1-year decline in estimated glomerular filtration rate (eGFR) after radical nephrectomy in patients with renal masses and matched living kidney donors is the same (pages E49–E55)

      Miki N. Hew, Dedan Opondo, Ernesto R. Cordeiro, Karlijn A.M.I. van Donselaar-van der Pant, Frederike J. Bemelman, Mirza M. Idu, Jean J.M.C.H. de la Rosette and M. Pilar Laguna

      Version of Record online: 31 OCT 2013 | DOI: 10.1111/bju.12345

    2. You have free access to this content
      National prospective study on the use of local haemostatic agents during partial nephrectomy (pages E56–E61)

      Herve Lang, Pascal Mouracade, Pierre Gimel, Jean C. Bernhard, Geraldine Pignot, Laurent Zini, Maxime Crepel, Jerome Rigaud, Laurent Salomon, Laurent Bellec, Christophe Vaessen, Morgan Roupret, Jean L. Jung, Eric Mourey, Xavier Martin, Pierre Bigot, Franck Bruyère, Julien Berger, Jean P. Ansieau, Franck Salome, Jacques Hubert, Christian Pfister, François Trifard, Marc Gigante, Herve Baumert, Arnaud Méjean and Jean J. Patard

      Version of Record online: 31 OCT 2013 | DOI: 10.1111/bju.12397

    3. You have free access to this content
      Evaluation of ABO blood group as a prognostic marker in renal cell carcinoma (RCC) (pages E62–E66)

      Michela de Martino, Matthias Waldert, Andrea Haitel, Georg Schatzl, Shahrokh F. Shariat and Tobias Klatte

      Version of Record online: 2 DEC 2013 | DOI: 10.1111/bju.12436

    4. You have free access to this content
      Cytoreductive nephrectomy in patients with metastatic non-clear-cell renal cell carcinoma (RCC) (pages E67–E74)

      Ayal A. Aizer, Yuksel Urun, Rana R. McKay, Adam S. Kibel, Paul L. Nguyen and Toni K. Choueiri

      Version of Record online: 14 FEB 2014 | DOI: 10.1111/bju.12442

    5. You have free access to this content
      Prevalence of dyslipidaemia in patients with renal cell carcinoma: a case-control study in China (pages E75–E81)

      Gui-Ming Zhang, Yao Zhu, Lei Luo, Hai-Liang Zhang, Cheng-Yuan Gu, Li-Jiang Sun and Ding-Wei Ye

      Version of Record online: 14 MAR 2014 | DOI: 10.1111/bju.12581

  3. Prostate

    1. Top of page
    2. Bladder
    3. Kidney
    4. Prostate
    5. Urothelial Carcinoma
    6. Translational Science
    1. You have free access to this content
      Clinical trial risk in castration-resistant prostate cancer: immunotherapies show promise (pages E82–E89)

      Alessandro Tenuta, Laurence Klotz and Jayson L. Parker

      Version of Record online: 2 DEC 2013 | DOI: 10.1111/bju.12309

    2. You have free access to this content
      A positive real-time elastography is an independent marker for detection of high-risk prostate cancers in the primary biopsy setting (pages E90–E97)

      Yngve Nygård, Svein A. Haukaas, Ole J. Halvorsen, Karsten Gravdal, Jannicke Frugård, Lars A. Akslen and Christian Beisland

      Version of Record online: 27 NOV 2013 | DOI: 10.1111/bju.12401

    3. You have free access to this content
      Prostate-specific antigen doubling time as a progression criterion in an active surveillance programme for patients with localized prostate cancer (pages E98–E105)

      Frederik Birkebæk Thomsen, Ib Jarle Christensen, Klaus Brasso, Martin Andreas Røder and Peter Iversen

      Version of Record online: 31 OCT 2013 | DOI: 10.1111/bju.12367

    4. You have free access to this content
      A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer (pages E106–E111)

      Simon P. Kim, R. Jeffrey Karnes, Paul L. Nguyen, Jeanette Y. Ziegenfuss, R. Houston Thompson, Leona C. Han, Nilay D. Shah, Marc C. Smaldone, Cary P. Gross, Igor Frank, Christopher J. Weight, Timothy J. Beebe and Jon C. Tilburt

      Version of Record online: 17 JAN 2014 | DOI: 10.1111/bju.12422

    5. You have free access to this content
      Population-based determinants of radical prostatectomy operative time (pages E112–E118)

      Stacey C. Carter, Stuart Lipsitz, Ya-Chen T. Shih, Paul L. Nguyen, Quoc-Dien Trinh and Jim C. Hu

      Version of Record online: 15 JAN 2014 | DOI: 10.1111/bju.12451

    6. You have free access to this content
      Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials (pages E119–E130)

      M. Diana van Die, Kerry M. Bone, Scott G. Williams and Marie V. Pirotta

      Version of Record online: 23 APR 2014 | DOI: 10.1111/bju.12435

    7. You have free access to this content
      Prospective analysis of penile length changes after radical prostatectomy (pages E131–E136)

      Boback M. Berookhim, Christian J. Nelson, Brian Kunzel, John P. Mulhall and Joseph B. Narus

      Version of Record online: 2 DEC 2013 | DOI: 10.1111/bju.12443

  4. Urothelial Carcinoma

    1. Top of page
    2. Bladder
    3. Kidney
    4. Prostate
    5. Urothelial Carcinoma
    6. Translational Science
    1. You have free access to this content
      A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma (pages E137–E143)

      Gregory R. Pond, Neeraj Agarwal, Joaquim Bellmunt, Toni K. Choueiri, Angela Qu, Ronan Fougeray, David Vaughn, Nicholas D. James, Yacine Salhi, Peter Albers, Günter Niegisch, Matthew D. Galsky, Yu-Ning Wong, Yoo-Joung Ko, Walter M. Stadler, Peter H. O'Donnell, Srikala S. Sridhar, Nicholas J. Vogelzang, Andrea Necchi, Giuseppe Di Lorenzo, Cora N. Sternberg, Amitkumar Mehta and Guru Sonpavde

      Version of Record online: 23 APR 2014 | DOI: 10.1111/bju.12564

    2. You have free access to this content
      Subclassification of upper urinary tract urothelial carcinoma by the neutrophil-to-lymphocyte ratio (NLR) improves prediction of oncological outcome (pages E144–E149)

      Hao-Lun Luo, Yen-Ta Chen, Yao-Chi Chuang, Yuan-Tso Cheng, Wei-Ching Lee, Chih-Hsiung Kang and Po-Hui Chiang

      Version of Record online: 14 MAR 2014 | DOI: 10.1111/bju.12582

  5. Translational Science

    1. Top of page
    2. Bladder
    3. Kidney
    4. Prostate
    5. Urothelial Carcinoma
    6. Translational Science
    1. You have free access to this content
      Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancer (pages E150–E156)

      Bao-Li Chang, Lucinda Hughes, David Y.T. Chen, Laura Gross, Karen Ruth and Veda N. Giri

      Version of Record online: 13 AUG 2013 | DOI: 10.1111/bju.12264

    2. You have free access to this content
      Polybromo-1 (PBRM1), a SWI/SNF complex subunit is a prognostic marker in clear cell renal cell carcinoma (pages E157–E163)

      Walter H. da Costa, Mariana Rezende, Felipe C. Carneiro, Rafael M. Rocha, Isabela W. da Cunha, Dirce M. Carraro, Gustavo C. Guimaraes and Stenio de Cassio Zequi

      Version of Record online: 2 DEC 2013 | DOI: 10.1111/bju.12426

    3. You have free access to this content
      Cyclooxygenase-2 inhibitor suppresses tumour progression of prostate cancer bone metastases in nude mice (pages E164–E177)

      Marta Garcia, Roberto Velez, Cleofé Romagosa, Blanca Majem, Núria Pedrola, Mireia Olivan, Marina Rigau, Marc Guiu, Roger R. Gomis, Juan Morote, Jaume Reventós and Andreas Doll

      Version of Record online: 14 FEB 2014 | DOI: 10.1111/bju.12503

SEARCH

SEARCH BY CITATION